...
首页> 外文期刊>Biomacromolecules >Calcium-Triggered Pulsatile Delivery of Parathyroid Hormone from Microbeads for Osteoporosis Treatment
【24h】

Calcium-Triggered Pulsatile Delivery of Parathyroid Hormone from Microbeads for Osteoporosis Treatment

机译:从微珠治疗微珠治疗钙甘露甲状腺激素的钙触发脉动递送

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Recombinant human parathyroid hormone 1-34 (rhPTH 1-34) is the most potent anabolic drug recommended for patients with osteoporosis who do not respond to conventional treatment. However, subcutaneous intermittent injection is the only effective regimen due to its unusual action of mechanism. This regimen is inconvenient and is a big hurdle in clinical applications. In this study, we designed polyelectrolyte microbeads that can deliver rhPTH 1-34 in response to Cat(2+) concentration, which indicates the osteoporotic status. Dextran photopolymer was synthesized, mixed with anionic monoacrylate, and photopolymerized by passing through capillary microfluidics to obtain the microbeads. The anionic property of microbeads was confirmed by toluidine blue staining. One microbead, loaded with a 1 day dose of rhPTH 1-34 (23.4 +/- 0.9 mu g), released rhPTH 1-34 in a triggered manner following the addition of Ca2+ ion. In vitro cell study demonstrated that rhPTH 1-34 released in a pulsatile manner from the microbeads induced osteogenic markers (ALP, RUNX2, and OPN) and precipitated mineral disposition more effectively.
机译:重组人甲状旁腺激素1-34(rhPth 1-34)是患有骨质疏松症患者的最有效的合成代谢药物,骨质疏松症患者不响应常规治疗。然而,皮下间歇注射是由于其不寻常的机制作用而唯一有效的方案。这个方案是不方便的,是临床应用中的大障碍。在本研究中,我们设计了聚电解质微珠,可以响应于猫(2+)浓度来提供rhPth 1-34,这表明骨质疏松状态。合成葡聚糖光聚合物,与阴离子单丙烯酸酯混合,并通过通过毛细管微流体光聚合以获得微珠。通过甲苯胺蓝染色证实了微珠的阴离子性能。在加入Ca2 +离子后,有一个微珠加载1天剂量的rhPth 1-34(23.4 +/-0.9μg),以触发的方式释放rhPth 1-34。体外细胞研究证明,rhPth 1-34以脉动方式从微珠诱导的骨质发生标记(ALP,RUNX2和OPN)和更有效地沉淀的矿物质布置。

著录项

  • 来源
    《Biomacromolecules》 |2017年第10期|共7页
  • 作者单位

    Inha Univ Coll Med Dept New Drug Dev WCSL B-308 Chungsuk Bldg 366 Seohae Daero Incheon 22332 South Korea;

    Inha Univ Coll Med Dept New Drug Dev WCSL B-308 Chungsuk Bldg 366 Seohae Daero Incheon 22332 South Korea;

    Inha Univ Coll Med Dept New Drug Dev WCSL B-308 Chungsuk Bldg 366 Seohae Daero Incheon 22332 South Korea;

    Inha Univ Coll Med Dept New Drug Dev WCSL B-308 Chungsuk Bldg 366 Seohae Daero Incheon 22332 South Korea;

    Inha Univ Coll Med Dept New Drug Dev WCSL B-308 Chungsuk Bldg 366 Seohae Daero Incheon 22332 South Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分子生物学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号